Real-world data (RWD) are a critical element of the evidence needed to help reach this goal, potentially informing a new drug’s development or providing insight for its use after it comes onto market. But current frameworks for analyzing RWD aren’t sufficient to provide the detailed, patient-level information that’s really needed for treatment decisions.
In this three-part research brief series, LEAPS envisions a learning health system where all stakeholders contribute to and benefit from the knowledge produced.
Share the research